Trademark: 97461207
Word
CTX121
Status
Dead
Status Code
602
Status Date
Wednesday, May 31, 2023
Serial Number
97461207
Mark Type
4000
Filing Date
Thursday, June 16, 2022
Abandoned Date
Tuesday, May 16, 2023

Trademark Owner History

Classifications
5 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
CTX ONE TWO ONE; CTX ONE HUNDRED TWENTY ONE

Trademark Events
May 31, 2023
Abandonment Notice E-Mailed - Failure To Respond
May 31, 2023
Abandonment Notice Mailed - Failure To Respond
May 31, 2023
Abandonment - Failure To Respond Or Late Response
Feb 14, 2023
Notification Of Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action Written
Feb 7, 2023
Assigned To Examiner
Jun 30, 2022
New Application Office Supplied Data Entered
Jun 20, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24